Takeda Pharmaceutical Co ADR (NYSE:TAK) does about 2.10M shares in volume on a normal day but saw 1625742 shares change hands in the recent trading day. The company now has a market cap of 47.08B USD. Its current market price is $14.96, marking a decrease of -0.20% compared to the previous close of $14.99. The 52 week high reached by this stock is $15.43 whilst the lowest price level in 52 weeks is $12.57.
The consensus objective for the share price is $17.27, suggesting that the stock has a potential upside of 13.38% over the period.
FactSet Research has provided data showing that 3 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
BofA Securities also upgraded the stock to “Buy” from Neutral on March 16, 2023 at a price target of $20. Cowen upgraded its price target at $21-$24.
The current price level is 3.17%, 1.75%, and 5.36% away from its SMA20, SMA50, and SMA200 respectively, with the TAK price moving above the 50-day SMA on current market day. Takeda Pharmaceutical Co ADR (TAK) stock is down -0.47% over the week and -0.66% over the past month. Its price is 12.99% year-to-date and 11.64% over the past year.
To reach the target analysts have set, the stock logically needs to grow 13.38 percent from here.
Outstanding shares total 3.15B with insiders holding 0.01% of the shares and institutional holders owning 2.30% of the company’s common stock. The company has a return on investment of 0.97% and return on equity of 1.50%. The price to earnings ratio (P/E ratio) amounts to 68.84 while the forward price to earnings ratio is 21.76. The beta has a value of 0.26. Price to book ratio is 1.02 and price to sales ratio is 1.57.
